July 11, 2024
Via: PharmaphorumThe FDA sent the Danish drugmaker a complete response letter (CRL) declining to approve the drug, insulin icodec, saying that it needs more information on its manufacturing process, as well as more data on how well it performs in people with […]
Clinical Trials, Research and Development
October 4, 2022
Via: PharmaphorumCompared to once-daily basal insulin (insulin degludec or insulin glargine U100/U300) analogues, the 52-week ONWARDS 5 trial – an open-label efficacy and safety treat-to-target study of 1,085 insulin-naïve people with type 2 diabetes in a clinical practice setting – achieved […]
July 11, 2024
July 19, 2024
July 11, 2024
Copyright © 2024. All rights reserved
